These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 16925860
1. White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats. Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE. Br J Nutr; 2006 Sep; 96(3):539-44. PubMed ID: 16925860 [Abstract] [Full Text] [Related]
2. Experimental type 2 diabetes induces enzymatic changes in isolated rat enterocytes. Martínez IM, Morales I, García-Pino G, Campillo JE, Tormo MA. Exp Diabesity Res; 2003 Sep; 4(2):119-23. PubMed ID: 14630573 [Abstract] [Full Text] [Related]
3. Hypoglycaemic and anorexigenic activities of an alpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Tormo MA, Gil-Exojo I, Romero de Tejada A, Campillo JE. Br J Nutr; 2004 Nov; 92(5):785-90. PubMed ID: 15533267 [Abstract] [Full Text] [Related]
4. Morphological and enzymatic changes of the small intestine in an n0-STZ diabetes rat model. Tormo MA, Martínez IM, Romero de Tejada A, Gil-Exojo I, Campillo JE. Exp Clin Endocrinol Diabetes; 2002 May; 110(3):119-23. PubMed ID: 12012271 [Abstract] [Full Text] [Related]
5. Orally administered tryptophan and experimental type 2 diabetes. Tormo MA, Romero de Tejada A, Morales I, Paredes S, Sánchez S, Barriga C, Hernández R. Mol Cell Biochem; 2004 Jun; 261(1-2):57-61. PubMed ID: 15362485 [Abstract] [Full Text] [Related]
6. Sodium metavanadate affected control and streptozotocin-diabetic rat liver golgi complexes. Dabroś W, Goc A, Turyna B, Kordowiak AM. Pol J Pathol; 2006 Jun; 57(2):91-7. PubMed ID: 17019971 [Abstract] [Full Text] [Related]
7. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C, Schaan B, Oliveira E, Oliveira V, De Angelis K, Irigoyen M. Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [Abstract] [Full Text] [Related]
8. Effect of cerebrocrast on body and organ weights, food and water intake, and urine output of normal rats. Briede J, Stivrina M, Stoldere D, Vigante B, Duburs G. Cell Biochem Funct; 2008 Dec; 26(8):908-15. PubMed ID: 19039818 [Abstract] [Full Text] [Related]
9. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats. Adewole SO, Ojewole JA. Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509 [Abstract] [Full Text] [Related]
10. Isolation and activity of an alpha-amylase inhibitor from white kidney beans. Zhang XQ, Yang MY, Ma Y, Tian J, Song JR. Yao Xue Xue Bao; 2007 Dec; 42(12):1282-7. PubMed ID: 18338641 [Abstract] [Full Text] [Related]
11. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats. Shu XS, Lv JH, Tao J, Li GM, Li HD, Ma N. J Ethnopharmacol; 2009 Jul 30; 124(3):539-43. PubMed ID: 19454312 [Abstract] [Full Text] [Related]
12. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus. Briede J, Stivrina M, Stoldere Dz, Vigante B, Duburs G. Cell Biochem Funct; 2007 Jul 30; 25(6):673-80. PubMed ID: 16986170 [Abstract] [Full Text] [Related]
13. Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats. Yamaguchi M, Uchiyama S, Lai YL. Int J Mol Med; 2007 May 30; 19(5):803-7. PubMed ID: 17390086 [Abstract] [Full Text] [Related]
14. Protective effects of a calcium channel blocker on apoptosis in thymus of neonatal STZ-diabetic rats. Kaya Dağistanli F, Süsleyici Duman B, Oztürk M. Acta Histochem; 2005 May 30; 107(3):207-14. PubMed ID: 15964614 [Abstract] [Full Text] [Related]
15. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM. J Endocrinol; 2005 Jun 30; 185(3):457-65. PubMed ID: 15930172 [Abstract] [Full Text] [Related]
16. Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced type 1 diabetes mellitus. Patel R, Shervington A, Pariente JA, Martinez-Burgos MA, Salido GM, Adeghate E, Singh J. Ann N Y Acad Sci; 2006 Nov 30; 1084():71-88. PubMed ID: 17151294 [Abstract] [Full Text] [Related]
17. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin. Portha B, Serradas P. Am J Med; 1991 Jun 24; 90(6A):15S-21S. PubMed ID: 1831320 [Abstract] [Full Text] [Related]
18. Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound. Clark TA, Edel AL, Heyliger CE, Pierce GN. Can J Physiol Pharmacol; 2004 Oct 24; 82(10):888-94. PubMed ID: 15573149 [Abstract] [Full Text] [Related]
19. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Cilek A, Celebi N, Tirnaksiz F, Tay A. Int J Pharm; 2005 Jul 14; 298(1):176-85. PubMed ID: 15950411 [Abstract] [Full Text] [Related]
20. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats. Li M, Smee JJ, Ding W, Crans DC. J Inorg Biochem; 2009 Apr 14; 103(4):585-9. PubMed ID: 19203797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]